European Medical Solutions
0RGO.L
London Stock Exchange0.02
EUR
+0.00
- -
European Medical Solutions
0RGO.L
(London Stock Exchange)
Recent
price
0.02
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- European Medical Solutions SA (0RGO.L) engages in the design, development, manufacturing and marketing of high-performance medical imaging systems for digital radiology and bone densitometry. The company offers a comprehensive range of products including R/F solutions such as PLATINUM NEO, an intelligent system revolutionizing R/F workflow, and OPTIMA dRF; bone densitometry and body composition analysis equipment; chest and bone rooms with floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; mammography solutions; ultrasonic and X-ray bone densitometers; mobile X-ray units; floating panel tables; and motorized mobile radiology solutions like !M1, Onyx with carbon nanotube technology and zero-gravity arm, and Xavion. It operates internationally through a network of over 140 distributors, subsidiaries and joint ventures across Europe, Africa, Asia and the Americas, with Europe accounting for nearly 58% of activity; Africa and Asia showing over 65% and 67% revenue growth respectively in 2024. Founded in 1979 and headquartered in Ixelles, Belgium, with main manufacturing in Gallargues-le-Montreux, France, the company operates as a subsidiary of Diagnostic Medical Systems SA. In June 2024, DMS Imaging SA rebranded to European Medical Solutions SA, with DMS Imaging retained as the commercial brand, and executed a 352-for-1 share consolidation to reduce shares in circulation and volatility. Recent developments include the October 2023 merger with Solutions for Tomorrow integrating motorized mobile !M1 solutions and reorganization of the radiology business; launch of Onyx mobile radiology awarded the Innovation Prize by the French Society of Radiology and ADAM AI software integrated into !M1 at the 2024 European Congress of Radiology; strategic US agreements with Medlink Imaging and JPI Healthcare; liquidation of subsidiaries Apelem Spain and DMS Wellness; management of a February 2024 ransomware cyberattack; and selection by Ukrainian authorities for a EUR 11 million contract to deliver 120 !M1 Adam emergency radiology mobiles funded by the Ukraine Economic Resilience Fund, with first deliveries in 2025. In 2024, revenue reached EUR 45.1 million, up 11% from 2023, with EBITDA rising 69% to EUR 4.4 million and margin expanding to nearly 10%, driven by 48% branded sales via distributors and 52% white-label OEM agreements; radiology contributed 78% of revenue and bone densitometry 22%. EMS continues investments in AI-powered software, cybersecurity and new solutions like Onyx and Xavion for commercialization in 2025 under its #Imaging 2027 strategic plan targeting EUR 70 million revenue by 2027.